financetom
Business
financetom
/
Business
/
Hanover Insurance Q3 net income jumps 75%, driven by lower catastrophe losses
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hanover Insurance Q3 net income jumps 75%, driven by lower catastrophe losses
Oct 29, 2025 1:47 PM

Overview

* Hanover Q3 net income rises to $178.7 mln, driven by lower catastrophe losses

* Operating income for Q3 increases to $185.6 mln, reflecting strong underwriting

* Net premiums written in Q3 up 4.5% yr/yr, driven by pricing increases

Outlook

* Company highlights constructive market dynamics in Core Commercial and Specialty segments

* Company notes insulation from competitive auto market in Personal Lines

* Company emphasizes investment in capabilities for long-term success

Result Drivers

* LOWER CATASTROPHE LOSSES - Catastrophe losses decreased to $46.2 mln, improving combined ratio by 3.0 points

* INVESTMENT INCOME - Net investment income rose 27.5% due to higher earned yields and cashflows

* PRICING INCREASES - Net premiums written increased 4.5% driven by renewal price increases in Personal Lines, Core Commercial, and Specialty

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 $1.73

Premiums bln

Written

Q3 Net $178.7

Income mln

Q3 88.10%

Adjusted

Combined

Ratio

Q3 91.10%

Combined

Ratio

Q3 31.30%

Expense

Ratio

Q3 $185.6

Operatin mln

g Income

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the property & casualty insurance peer group is "buy"

* Wall Street's median 12-month price target for Hanover Insurance Group Inc ( THG ) is $198.00, about 14.7% above its October 28 closing price of $168.90

* The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 11 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nippon Steel says it has not received any update from CFIUS on US Steel deal
Nippon Steel says it has not received any update from CFIUS on US Steel deal
Dec 23, 2024
WASHINGTON, Dec 23 (Reuters) - Nippon Steel ( NISTF ) said on Monday it has not received any update from the Committee on Foreign Investment in the United States about the national security risks of the Japanese company's proposed acquisition of U.S. Steel. The Washington Post reported on Monday that CFIUS was unable to reach a consensus on the proposed...
CFIUS unable to reach consensus on Nippon Steel's U.S. Steel bid, WaPo reports
CFIUS unable to reach consensus on Nippon Steel's U.S. Steel bid, WaPo reports
Dec 23, 2024
(Reuters) - The Committee on Foreign Investment in the United States (CFIUS) has told the White House it is unable to reach a consensus on national security risks involved in Nippon Steel's ( NISTF ) bid for U.S. Steel, the Washington Post reported on Monday. The high-level government review board delivered its final evaluation of the deal late on Monday,...
US says former Humanigen chief scientific officer charged with insider trading
US says former Humanigen chief scientific officer charged with insider trading
Dec 23, 2024
WASHINGTON, Dec 23 (Reuters) - An indictment unsealed on Monday charged the former chief scientific officer of biopharmaceutical company Humanigen with engaging in an insider trading scheme involving the firm's stock, the U.S. Justice Department said. Between June and August of 2021, Dale Chappell, 54, avoided more than $38 million in losses by selling millions of shares of Humanigen stock...
Amicorp Group denies alleged fraud of over $7 billion in Malaysia's 1MDB scandal
Amicorp Group denies alleged fraud of over $7 billion in Malaysia's 1MDB scandal
Dec 23, 2024
KUALA LUMPUR, Dec 24 (Reuters) - Corporate services provider Amicorp Group has denied allegations it knowingly facilitated more than $7 billion in fraudulent transactions related to the misappropriation of funds from Malaysian state fund 1Malaysia Development Berhad. Amicorp will defend itself and dispute the relief sought by 1MDB in court following a legal claim of more than $1 billion filed...
Copyright 2023-2026 - www.financetom.com All Rights Reserved